Malaysia was recently chosen as the platform for China’s MEBO International to further progress their involvement with United Nation’s “Every Woman Every Child China Partnership Network (EWECCPN) Life Regenerative Action Programme”. They launched their initiative on 27 July at Mandarin Oriental, Kuala Lumpur to mark this prominent move.

YBhg Dato’ Hajah Mariam Mas bt Yacob, Chairman of National Population and Family Development Board (LPPKN), officiated the event in front of over 200 attendees. Other VIPs who graced the event included Mr Zhang Heqiang, Director General, Department of American & Oceanian Affairs, Chinese People’s Association for Friendship with Foreign Countries, Mr Kevin Xu, Chairman of MEBO International and Ms Ma Jia, Minister Counsellor, Embassy of China in Malaysia.

Besides that, the respected YBhg Dato’ Abdul Majid Ahmad Khan, President of Malaysia-China Friendship Association, and Dr Noor Haliza Yusoff, Senior Consultant, Obstetrics and Gynaecology Department, Hospital Kuala Lumpur also actively participated in kickstarting this event.

MEBO’s 5-year action plan comprises of rescuing over 1,000 women and children


In 2010, United Nations Secretary General Ban Ki-moon introduced the “Every Woman Every Child” programme. As Mr Xu shared in his opening remarks, the aim here was to leverage “the collective strengths of government institutions, corporations and civil society members to forge cross-sector cross-industry partnerships to support development strategies for women’s and children’s health in all countries.”

Mr Kevin Xu announced that MEBO International will donate 5,000 tubes of ointment to Malaysia this year.
Mr Kevin Xu announced that MEBO International will donate 5,000 tubes of ointment to Malaysia this year.

Subsequently, MEBO International joined this initiative in May 2016. They announced the development of the China Partnership Network (CPN) as well as MEBO’s action plan to provide supportive medical assistance in Asia and Africa.

“The action will be carried out by three steps in the next five years,” explained Mr Zhang, “with the target of rescuing over 1,000 women and children patients suffering from poverty in China, Africa, South America, Southeast Asia and East Asia; providing life regeneration techniques and medical supplies to the recipient countries; holding training courses for local doctors; as well as promoting local economic development by international trade in the medical field.”

Currently, MEBO International – known as the birthplace of human body regenerative medicine – holds over 40 patents in various countries and regions, for example China, America, Europe and Japan, including patents for regenerating core human organs.

Annually, statistics show 265,000 people – mostly from low and middle-income countries – succumb to burns. It ranks as the 11th major cause of death for children between 1 and 9 years old. Thus, Mr Xu stressed on the importance of reducing the global disability and mortality rates of women and children with burns in line with the Every Woman Every Child Initiative.

He announced that MEBO International will be donating 5,000 tubes of MEBO ointment to Malaysia this year, and 10,000 tubes in 2018 and 2019, respectively. Dato’ Hajah Mariam added to that stating, “Under the Corporate Social Responsibility (CSR) programme in Malaysia, 10 dedicated doctors from China will be located in various hospitals in Malaysia with a focus on helping woman and children in need of better health. The medical teams will provide free medical services.”

Dr Noor Haliza (centre) urged healthcare professionals to be more open in exploring treatment options for their patients.
Dr Noor Haliza (centre) urged healthcare professionals to be more open in exploring treatment options for their patients.

Applicability and acceptance of MEBO in Malaysia’s healthcare setting


Following the launch ceremony, Director of MEBO Healthcare Sdn Bhd Mr Manhon Shiew, explained at the press conference regarding the contents of the product and its role in providing a suitable environment to promote stem cells regeneration in the body.

Dr Noor Haliza shared her experiences as a clinician in using the MEBO product. She greatly advocates for it because she believed her patients benefited greatly with the availability of this type of treatment.

However, she noted the scepticism received from her colleagues and, potentially, from other clinicians in the country. She clarified, “As doctors and healthcare professionals, it is hard for us to believe in things besides what we have learnt in medical school. So, it takes a lot of time and effort to change that mindset.” MIMS

Read more:
Public health experts say violence and conflict deprives children of the most basic healthcare
MSD Malaysia launches dual-mechanism drug that significantly lowers LDL-C levels
MDA returns with its 23rd National Conference—zooming into “Advancing Clinical Nutrition Care in Dietetics”